*To the Editor*:

The outbreak of coronavirus disease 2019 (COVID-19) is spreading rapidly \[[@C1]--[@C8]\]. On 31 January 2020, the World Health Organization declared COVID-19 a public health emergency of international concern. By 13 March 2020, COVID-19 had been confirmed in 127 countries, with 145 166 cases and 5428 deaths worldwide.

At an early stage of the epidemic, older adults were reported to be more likely to be infected \[[@C1]--[@C8]\]. Subsequently, infections in infants under 1 year of age were reported \[[@C8]\]. To date, little is known about the infection in newborn babies. Furthermore, data regarding intrauterine transmission are scarce \[[@C9]\]. In this study, we identified all infected newborn babies in China by 13 March 2020 and describe the clinical features, treatment, outcomes and intrauterine transmission potential.

For this retrospective study, we identified all neonatal infections with the COVID-19 virus, SARS-CoV-2, between 8 December 2019 and 13 March 2020 in China. The summary number of new infections was released daily by the National Health Commission in China \[[@C10]\]. We systematically explored all the 81 026 cases that were laboratory-confirmed by 13 March 2020, as described previously \[[@C8]\]. In short, we retrieved the summary data from the central government and local health departments and screened for newborn babies \<28 days of age. Local hospitals, administrative offices and families of patients were interviewed through telephone or online communication tools. This study was approved by the institutional review board of Wuhan University School of Health Sciences. The need for informed consent was waived as part of the public health outbreak investigation.

Data on the demographics, disease onset, diagnosis, treatment and outcomes were collected using standard forms. To analyse the intrauterine transmission potential, data were collected on the mother\'s disease onset (symptoms, timing of symptoms onset relative to delivery), diagnosis, Wuhan linkage (living in or visited Wuhan, or directly contacting visitors from Wuhan), delivery (delivery methods, hospital level, protection level, gestational age at delivery) and mother--child contact (separation, breastfeeding).

To detect neonatal infection, nasopharyngeal swabs or anal swabs were collected during hospitalisation. Quantitative real-time PCR was used according to the recommended protocol \[[@C11]\]. IgM/IgG antibodies were not used in the present study because this technology has been developed recently and had not been widely used at this stage.

For the mothers of the newborn babies, computed tomography (CT) scanning was used for preliminary screening. Abnormal results included ground-glass opacity and bilateral patchy shadowing. Suspected infection was defined as abnormal results on CT scanning coupled with typical clinical symptoms, including fever, cough, headache, sore throat, shortness of breath and sputum production. Nasopharyngeal swabs were collected for detection of SARS-CoV-2 nucleic acid. Confirmation of infection in mothers was based on nucleic acid tests.

Based on the data sources we used in this retrospective study, four nucleic acid-confirmed neonatal infections were identified through systematic and comprehensive searching among the 81 026 confirmed cases in China as of 13 March 2020 ([table 1](#TB1){ref-type="table"}). All four patients were hospitalised. Three were male. The age at diagnosis ranged from 30 h to 17 days.

###### 

Characteristics of four hospitalised nucleic acid-confirmed infections in newborn babies

                                                                 **Patient 1**            **Patient 2**                         **Patient 3**                        **Patient 4**
  --------------------------------------------------------- ------------------------ ------------------------ ------------------------------------------------- ------------------------
  **Demographics**                                                                                                                                              
   Sex                                                                Male                     Male                                 Male                                 Female
   Age at diagnosis                                                   30 h                   17 days                               5 days                                5 days
  **Disease onset**                                                                                                                                             
   Onset of symptoms                                          Shortness of breath     Fever, cough, vomiting                        Fever                             No symptoms
   Setting of disease onset                                         Hospital                   Home                                 Home                                Hospital
   Status of isolation                                        Isolated in hospital         No isolation                         No isolation                      Isolated in hospital
  **Diagnosis**                                                                                                                                                 
   Nucleic acid detection                                             Yes                      Yes                                   Yes                                  Yes
   Time between symptoms onset and nucleic acid diagnosis           Same day                  2 days                              Same day                             5 days^\#^
   Nucleic acid specimen swab                                    Nasopharyngeal                Anal                                 Anal                             Nasopharyngeal
   CT scan test                                              Increased lung marking   Increased lung marking                                                     Increased lung marking
  **Treatment**                                                                                                                                                 
   Supportive treatment                                               Yes                      Yes                                   Yes                                  Yes
   Intensive care unit                                                 No                       No                                   No                                    No
   Mechanical ventilation                                              No                       No                                   No                                    No
  **Outcomes**                                                                                                                                                  
   Any severe complications                                            No                       No                                   No                                    No
   Hospital stay days                                                  14                       23                                   30                                    16
  **Mother\'s disease onset**                                                                                                                                   
   Symptoms                                                          Fever                    Cough            Fever, cough, appetite decline, oil intolerance           Fever
   Timing of symptoms onset                                     Before delivery           After delivery                       Before delivery                      Before delivery
  **Mother\'s disease diagnosis**                                                                                                                               
   Infection status                                                   Yes                      Yes                                   Yes                                  Yes
   CT diagnosis                                                 Before delivery           After delivery                       Before delivery                      Before delivery
   Nucleic acid detection                                        After delivery           After delivery                       After delivery                        After delivery
  **Epidemiology**                                                                                                                                              
   Linkage to Wuhan                                            Residing in Wuhan        Residing in Wuhan                      Visiting Wuhan                      Residing in Wuhan
   Contact with patients                                               No                Household member                            No                                    No
  **Delivery**                                                                                                                                                  
   Method of delivery                                              Caesarean                Caesarean                             Caesarean                            Caesarean
   Hospital level                                                     III                      III                                   II                                   III
   Protection level                                                   III                       II                                   III                                  III
   Gestational age                                              39 weeks, 6 days              Mature                               Mature                           40 weeks, 1 day
  **Mother--child contact**                                                                                                                                     
   Immediate separation                                               Yes                       No                                   Yes                                  Yes
   Breastfeeding                                                       No                      Yes                                   No                                    No

CT: computed tomography. ^\#^: time between date of birth and diagnosis.

Two newborn babies had fever, one had shortness of breath, one had cough and one had no noticeable symptoms. The onset of disease occurred in hospital for two newborn babies and at home for two newborn babies. Two newborn babies were in isolation and two were not in isolation at the time of disease onset.

Nucleic acid detection was performed using nasopharyngeal swabs for two newborn babies and anal swabs for two newborn babies. All four newborn babies tested positive for SARS-CoV-2 nucleic acid. CT scans were performed in three newborn babies. All showed increased lung marking. The time between dates of admission/symptoms and diagnosis was 0--2 days.

Supportive treatment was provided for all four newborn babies. None required intensive unit care or mechanical ventilation. None had any severe complications. Three newborn babies were deemed to recover after two consecutive negative nucleic acid tests (separated by ≥24 h). Their hospital stay was 16, 23 and 30 days, respectively.

All four newborn babies' mothers were diagnosed as infected. Three mothers showed symptoms before delivery and one after delivery. The most common symptoms in mothers were fever, followed by cough, appetite decline and oil intolerance. CT scans were performed for all four mothers, with three before and one after delivery. Abnormal findings were reported for all mothers. Nucleic acid detection was performed for all four mothers, with three after delivery and one before delivery. All four mothers tested positive for SARS-CoV-2 nucleic acid.

Caesarean section was used for all four mothers, three at level III hospitals and one at a level II hospital. The protection level was III for three mothers and II for one mother. Three newborn babies were separated from their mothers immediately after being born and were not breastfed; one neonate had not been separated from the mother and was breastfed for 16 days until symptom onset.

Based on these findings, symptoms of neonatal infection appear to be generally mild compared to adult patients. No severe clinical complications or deaths were observed in newborn babies, compared to fatality rates of ∼4--15% in adults \[[@C1]--[@C4]\]. Note that infants \<1 year of age also presented mild or no symptoms and rarely severe complications \[[@C8]\]. On the one hand, it is encouraging that newborn babies and infants appear to have mild symptoms, although close monitoring for clinical deterioration is still necessary. On the other hand, mild or no symptoms in the youngest make it difficult to detect and prevent further transmission of this virus in the general population.

The number of neonatal infections was four, compared to the previously reported nine infections in infants aged between 28 days and 1 year \[[@C8]\]. Proportionately, the infection rate might be higher in newborn babies than infants. Different exposure chances may partly explain the different infection rates, but different transmission routes may be another explanation. Vertical transmission may be an additional route for infections in newborn babies but not possible for infants, although a previous study of six pregnant women did not find any direct evidence \[[@C9]\].

The findings of the present study suggest intrauterine transmission potential. All four newborn babies were delivered through caesarean section and three were under level III protection. The possibility of intrapartum mother-to-child transmission by vaginal delivery was excluded. Except for patient 2 having contact with an infected visitor, all the other three newborn babies were in isolation when symptoms occurred. No mother--child contact or breastfeeding occurred in these three newborn babies. The time between birth and diagnosis was limited, ranging between 30 h and 5 days. Taken together, the chance of infection through ways other than intrauterine transmission is deemed to be low. However, there are other explanations for neonatal infections. Firstly, the possibility of nosocomial infection cannot be completely ruled out. Secondly, nasopharyngeal and anal swabs cannot directly indicate intrauterine infection, and no viral particles were found in the amniotic fluid or cord blood from six patients \[[@C9]\]. Thirdly, the number of neonatal infections is small, although it is possible that the identification of cases was incomplete due to a lack of identifying information for newborn babies. Fourthly, SARS-CoV, another coronavirus with a similar genome sequence \[[@C12]\], was not found to be vertically transmitted \[[@C13], [@C14]\]. Further research is warranted.

There are limitations to the present study. First, although a systematic and comprehensive search was made for SARS-CoV-2 infection in newborn babies \<28 days of age, incomplete identification of cases is possible. Secondly, the present study identified mostly symptomatic patients. However, asymptomatic infection exists for COVID-19 \[[@C8], [@C15]\]. Thirdly, intrauterine tissue samples were not collected for these four newborn babies. Direct intrauterine detection of SARS-CoV-2 was not possible in the present study.

In summary, newborn babies are susceptible to SARS-CoV-2 infection. The symptoms in newborn babies were milder and outcomes were less severe compared to adult patients. Intrauterine vertical transmission is not impossible, and further studies are warranted to search for virological evidence.

Shareable PDF {#s2}
=============

10.1183/13993003.00697-2020.Shareable1

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00697-2020.Shareable

Supplementary Material
======================

###### ERJ-00697-2020.Shareable.pdf

Author contributions: Zhi-Jiang Zhang conceived the study and drafted the manuscript; Zhi-Jiang Zhang collected data; Xue-Jie Yu, Tao Fu, Yu Liu, Yan Jiang, Bing Xiang Yang and Yongyi Bi edited the manuscript.

Conflict of interest: Zhi-Jiang Zhang has nothing to disclose.

Conflict of interest: Xue-Jie Yu has nothing to disclose.

Conflict of interest: Tao Fu has nothing to disclose.

Conflict of interest: Yu Liu has nothing to disclose.

Conflict of interest: Yan Jiang has nothing to disclose.

Conflict of interest: Bing Xiang Yang has nothing to disclose.

Conflict of interest: Yongyi Bi has nothing to disclose.

Support statement: This work was supported by the Fundamental Research Funds for the Central Universities (2042020kfxg04).
